Investors / United States / Global Source Ventures
Global Source Ventures
Venture capital · San Diego, CA, United States · North America
Global Source Ventures provides capital, management and advisory services to early-stage life sciences companies. It maintains ownership interests in portfolio companies through equity investments, convertible notes, stock options and warrants.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechnologyhealthcaretherapeuticssustainabilityearly stage
Your fit with Global Source Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsGlobal Source Ventures lists 9 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (75%), Industrial & Manufacturing (13%) and Other (13%). 80% of its companies are based in United States. It invests most often alongside Mesa Verde Venture Partners, ARCH Venture Partners and Aisling Capital.
No funding round on record names Global Source Ventures yet, so the figures come from its portfolio page.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 93th | 75% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers889%
- No longer answers00%
- Points to another company111%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 75% | 15% |
| Industrial & Manufacturing | 13% | 7% |
| Other | 13% | 0% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Mesa Verde Venture Partners
Compare Global Source Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
9 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Annikki GmbH develops and licenses technologies for cell-free redox biocatalysis and biomass fractionation to produce bio-based chemicals. | Industrial & Manufacturing | Portfolio page | ||
| Avalyn Pharma develops inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. | Healthcare & Biotech | Portfolio page | ||
| Immusoft engineers B cells as biofactories for therapeutic protein delivery | Healthcare & Biotech | Portfolio page | ||
| The company is a clinical-stage oncology company | Healthcare & Biotech | Portfolio page | ||
| Retrotope is developing a pipeline of proprietary therapeutics designed to treat degenerative disease by down-regulating lipid peroxidation in order to protect against cellular degeneration. | Healthcare & Biotech | Portfolio page | ||
| The company develops therapies for autoimmune diseases, specifically a first-in-class Kv1.3 blocker called si-544. | Healthcare & Biotech | Portfolio page | ||
| Treemera has developed a process to produce furandicarboxylic acid, a key raw material for bioplastics. | Other | Portfolio page | ||
Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- globalsourceventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 9
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Global Source Ventures' profile as data
Pull Global Source Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/globalsourceventures.com
# also
GET /v1/firms/globalsourceventures.com/portfolio
GET /v1/firms/globalsourceventures.com/coinvestors
GET /v1/firms/globalsourceventures.com/news